Boston Scientific Corp (NYSE:BSX)

42.33
Delayed Data
As of Aug 12
 +0.57 / +1.36%
Today’s Change
34.98
Today|||52-Week Range
47.50
-0.35%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$60.6B

Company Description

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment consists of technologies for diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979, and is headquartered in Marlborough, MA.

Contact Information

Boston Scientific Corp.
300 Boston Scientific Way
Marlborough Massachusetts 01752-1234
P:(508) 683-4000
Investor Relations:
(508) 683-4479

Employees

Shareholders

Mutual fund holders54.55%
Other institutional39.32%
Individual stakeholders1.45%

Top Executives

Michael F. MahoneyChairman, President & Chief Executive Officer
Edward F. MackeyExecutive Vice President-Global Operations
Daniel J. BrennanChief Financial Officer & Executive Vice President
Jodi EddySenior VP, Chief Information & Digital Officer
Ian T. MeredithGlobal Chief Medical Officer & Executive VP